Bregma Capital Life Sciences Fund, LP
Bregma Capital Life Sciences Fund, LP is a hedge fund based in San Francisco, California. Its most recent Form D, filed Aug 31, 2026, reports no sales yet. The minimum investment it accepts from an outside investor is $1,000,000. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Mark Karvosky; Bregma Capital GP, LLC; Bregma Capital, LP.
Performance
No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $0Cumulative sales reported on Form D
- Investors
- 0
- First sale
- —
- Minimum investment
- $1,000,000
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Mark Karvosky; Bregma Capital GP, LLC; Bregma Capital, LP
- Latest Form D
- Aug 31, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Bregma Capital Life Sciences Fund, LP
What is the minimum investment for Bregma Capital Life Sciences Fund, LP?
According to its latest Form D, filed Aug 31, 2026, the minimum investment Bregma Capital Life Sciences Fund, LP accepts from an outside investor is $1,000,000.
Who can invest in Bregma Capital Life Sciences Fund, LP?
Bregma Capital Life Sciences Fund, LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Bregma Capital Life Sciences Fund, LP raised?
Bregma Capital Life Sciences Fund, LP's latest Form D, filed Aug 31, 2026, reports no sales yet.
Where is Bregma Capital Life Sciences Fund, LP based?
Bregma Capital Life Sciences Fund, LP is based in San Francisco, California.
Size compared with every hedge fund
This fund hasn't reported any sales yet.